| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CPRX | Common stock, par value $0.001 per share | Options Exercise | $23,700 | +30,000 | +9.6% | $0.7900 | 343,541 | 05 Apr 2023 | Direct | |
| transaction | CPRX | Common stock, par value $0.001 per share | Sale | $504,900 | -30,000 | -8.7% | $16.83 | 313,541 | 05 Apr 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CPRX | Options to purchase common stock | Options Exercise | $0 | -30,000 | -9.7% | $0.000000 | 280,500 | 05 Apr 2023 | Common Stock | 30,000 | $0.7900 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Dr. Tierney has advised the Company that the sale of shares was to pay the exercise price of the shares and to raise funds for personal reasons, and does not relate to any disagreements between Dr. Tierney and the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company. |
| F2 | Shares were sold in various lots from $16.70 to $16.98 per share. The listed sales price represents a weighted average price for the shares sold. |
| F3 | The option was granted on June 15, 2016 and previously vested in two annual installments. |